Pharma Journalist 8916 posts 0 comments

Epizyme, Inc. a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, and HUTCHMED (China) Limited (“HUTCHMED”), announce a…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset Pompe disease, a…
Read More...

Kite, a Gilead Company and Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer…
Read More...

SMi Group reports: Ten key reasons to join SMi’s Next Generation Pharmaceutical Cleanroom conference, convening on 6th and 7th October 2021. The 2nd Annual Next Generation…
Read More...

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced that it has received FDA approval for generic Isoproterenol Hydrochloride USP, (0.2…
Read More...

Bayer AG announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company utilizing novel discovery technologies to unlock high value,…
Read More...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase II open-label trial of AKS-452, its…
Read More...

SMi Group reports: Hear from industry expert Alexandar Stoll, Frensenius Kabi AB on the latest updates in the Aseptic Processing field ahead of the conference this September. The…
Read More...

NRx Pharmaceuticals (NRx) announced it has signed an agreement with MannKind Corporation to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human Vasoactive…
Read More...

BioNTech SE and Kite, a Gilead Company announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing…
Read More...